Adherence to extended release tolterodine versus immediate- and extended-release oxybutynin among commercially-insured patients with overactive bladder

被引：0

作者：

Ollendorf, DA

Jumadilova, Z

Varadharajan, S

Girase, P

机构：

[1] Pharmetrics, Watertown, MA USA

[2] Pfizer Inc, New York, NY USA

来源：

VALUE IN HEALTH | 2005年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)63137-3

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：416 / 416

页数：1

共 50 条

[1] Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially-insured persons with overactive bladder
Ollendorf, D
Jumadilova, Z
Varadharajan, S
Girase, P
VALUE IN HEALTH, 2005, 8 (06) : A79 - A79
[2] Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder
Varadharajan, S
Jumadilova, Z
Girase, P
Ollendorf, DA
AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (04): : S140 - S149
[3] Extended-release oxybutynin and tolterodine treat overactive bladder
Ables, AZ
JOURNAL OF FAMILY PRACTICE, 2003, 52 (11): : 829 - 830
[4] Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder
Getsios, D
Caro, JJ
Ishak, KJ
El-Hadi, W
Payne, K
CLINICAL THERAPEUTICS, 2004, 26 (03) : 431 - 438
[5] Tolterodine extended-release for overactive bladder
Chung, Doreen E.
Te, Alexis E.
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2181 - 2194
[6] A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women
Peter K. Sand
John Miklos
Henry Ritter
Rodney Appell
International Urogynecology Journal, 2004, 15 : 243 - 248
[7] A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women
Sand, PK
Miklos, J
Ritter, H
Appell, R
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2004, 15 (04) : 243 - 248
[8] Treatment of overactive bladder: A model comparing extended-release formulations of tolterodine and oxybutynin
Perfetto, EM
Subedi, P
Jumadilova, Z
AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (04): : S150 - S157
[9] Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder
Bolge, Susan C.
McDonnell, Diana D.
Chen, Andrew
Wan, George J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1903 - 1912
[10] Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder
Rodney U. Anderson
Scott MacDiarmid
Sherron Kell
James H. Barada
Scott Serels
Roger P. Goldberg
International Urogynecology Journal, 2006, 17 : 502 - 511

← 1 2 3 4 5 →